Article

Telemedicine may help identify, treat diabetic retinopathy

With diabetes cases worldwide expected to double in the first 30 years of the 21st century, telemedicine might be a pathway to ensuring that more patients receive care, and thus, prevent complications from retinopathy, said P. Lloyd Hildebrand, MD, Dean A. McGee Eye Institute, Oklahoma University Health Sciences Center.

With diabetes cases worldwide expected to double in the first 30 years of the 21st century, telemedicine might be a pathwayto ensuring that more patients receive care, and thus, prevent complications from retinopathy, said P. Lloyd Hildebrand, MD,Dean A. McGee Eye Institute, Oklahoma University Health Sciences Center.

"Remote retinal imaging with centralized interpretation allows for increased access, quality, and efficiency," he said. Thisis especially true for a largely rural population.

Putting together a telemedicine program is not easy, however, Dr. Hildebrand said. He offered a 10-step approach:

  • Decide whether you want to target detection or diagnostic evaluation. This knowledge will affect the protocols andtechnologies you'll implement.
  • Plan to measure the quality of your efforts through five parameters: reproducibility, technical referral rate, number ofungradeable eyes, accuracy, and compliance.
  • Develop a viable business model. "This may be the biggest problem to developing a program, especially in the UnitedStates," Dr. Hildebrand said. "Margins are tight, and you're dealing with highly variable health plan reimbursementpolicies."
  • Generate useful reports.
  • Push compliance. Programs that drive compliance, such as disease registries and call systems, will be important.
  • Educate, educate, educate. Because much of diabetes is a primary-care disease, enlist the help of primary-care physiciansto inform patients about the seriousness of diabetic retinopathy and to encourage them to participate.
  • Plan for the outliers-you will encounter patients who have other pathologies.
  • Provide a solution; have an outlet to provide treatment.
  • Understand the barriers, whether those are geographical, governmental, etc.
  • Understand that many questions about retinopathy remain to be answered.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.